Sofie Haglund

452 total citations
17 papers, 342 citations indexed

About

Sofie Haglund is a scholar working on Public Health, Environmental and Occupational Health, Surgery and Infectious Diseases. According to data from OpenAlex, Sofie Haglund has authored 17 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 4 papers in Surgery and 3 papers in Infectious Diseases. Recurrent topics in Sofie Haglund's work include Acute Lymphoblastic Leukemia research (8 papers), Inflammatory Bowel Disease (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Sofie Haglund is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Inflammatory Bowel Disease (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Sofie Haglund collaborates with scholars based in Sweden, Qatar and Germany. Sofie Haglund's co-authors include Sven Almér, Curt Peterson, Jan Taipalensuu, Malin Lindqvist, Jan Söderman, Anders Isaksson, Elisabeth Gustavsson, Gunnar Nordin, W. Gerhardt and Hugo A. Katus and has published in prestigious journals such as Gastroenterology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Sofie Haglund

17 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofie Haglund Sweden 9 191 74 67 60 55 17 342
Marie Balsat France 11 121 0.6× 12 0.2× 34 0.5× 46 0.8× 33 0.6× 41 332
Hiromichi Take Japan 11 56 0.3× 26 0.4× 31 0.5× 45 0.8× 14 0.3× 31 299
A Lo United States 11 52 0.3× 7 0.1× 21 0.3× 20 0.3× 29 0.5× 35 366
Susana Sampaio Portugal 11 19 0.1× 21 0.3× 26 0.4× 22 0.4× 10 0.2× 36 312
Ana Isabel Piqueras Spain 7 17 0.1× 14 0.2× 67 1.0× 31 0.5× 17 0.3× 22 320
Sonoko Shimoji Japan 9 23 0.1× 9 0.1× 185 2.8× 28 0.5× 22 0.4× 24 449
Francesco Licciardi Italy 11 25 0.1× 11 0.1× 71 1.1× 10 0.2× 44 0.8× 27 299
Florence Aulagnon France 7 37 0.2× 7 0.1× 24 0.4× 15 0.3× 10 0.2× 9 375
Christie L. Boils United States 8 39 0.2× 10 0.1× 72 1.1× 15 0.3× 31 0.6× 11 289
Fatma Tuncay Özgünen Türkiye 12 97 0.5× 23 0.3× 24 0.4× 198 3.3× 18 0.3× 35 412

Countries citing papers authored by Sofie Haglund

Since Specialization
Citations

This map shows the geographic impact of Sofie Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Haglund more than expected).

Fields of papers citing papers by Sofie Haglund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Haglund. The network helps show where Sofie Haglund may publish in the future.

Co-authorship network of co-authors of Sofie Haglund

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Haglund. A scholar is included among the top collaborators of Sofie Haglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Haglund. Sofie Haglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Haglund, Sofie, Jan Söderman, & Sven Almér. (2023). Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders. International Journal of Molecular Sciences. 24(6). 5820–5820. 8 indexed citations
2.
Haglund, Sofie, et al.. (2021). CXCL13 in laboratory diagnosis of Lyme neuroborreliosis—the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples. European Journal of Clinical Microbiology & Infectious Diseases. 41(1). 175–179. 8 indexed citations
3.
Dimberg, Jan, Roland E. Andersson, & Sofie Haglund. (2020). Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade. Oncology. 98(8). 575–582. 3 indexed citations
4.
Henningsson, Anna J., et al.. (2017). Rapid diagnosis of acute norovirus-associated gastroenteritis: evaluation of the Xpert Norovirus assay and its implementation as a 24/7 service in three hospitals in Jönköping County, Sweden. European Journal of Clinical Microbiology & Infectious Diseases. 36(10). 1867–1871. 13 indexed citations
5.
Haglund, Sofie, Svante Vikingsson, Sven Almér, & Jan Söderman. (2017). Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells – Effects on gene expression levels and thiopurine metabolism. PLoS ONE. 12(3). e0173825–e0173825. 5 indexed citations
6.
Haglund, Sofie, et al.. (2017). Xpert Flu as a rapid diagnostic test for respiratory tract viral infection: evaluation and implementation as a 24/7 service. Infectious Diseases. 50(2). 140–144. 3 indexed citations
7.
Haglund, Sofie, Sven Almér, Curt Peterson, & Jan Söderman. (2013). Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease – Novel Clues to Drug Targets and Disease Mechanisms?. PLoS ONE. 8(2). e56989–e56989. 13 indexed citations
8.
Haglund, Sofie, Svante Vikingsson, Jan Söderman, et al.. (2011). The Role of Inosine-5′-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease. Therapeutic Drug Monitoring. 33(2). 200–208. 22 indexed citations
9.
Haglund, Sofie. (2011). Interindividual differences in thiopurine metabolism : studies with focus on inflammatory bowel disease. KTH Publication Database DiVA (KTH Royal Institute of Technology). 2 indexed citations
10.
11.
Haglund, Sofie, Svante Vikingsson, Jan Taipalensuu, et al.. (2009). W1208 A ‘Skewed’ Thiopurine Metabolite Profile in IBD Patients Is Not Explained By Variations in Inosine-5-Monophosphate Dehydrogenase Activity. Gastroenterology. 136(5). A–678. 1 indexed citations
12.
Haglund, Sofie, Jan Taipalensuu, Curt Peterson, & Sven Almér. (2007). IMPDH activity in thiopurine‐treated patients with inflammatory bowel disease – relation to TPMT activity and metabolite concentrations. British Journal of Clinical Pharmacology. 65(1). 69–77. 50 indexed citations
13.
Lindqvist, Malin, et al.. (2004). Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics. 14(4). 261–265. 65 indexed citations
14.
Grodzinsky, Ewa, et al.. (2004). Point‐of‐care testing has a limited effect on time to clinical decision in primary health care. Scandinavian Journal of Clinical and Laboratory Investigation. 64(6). 547–552. 8 indexed citations
15.
Haglund, Sofie, Malin Lindqvist, Sven Almér, Curt Peterson, & Jan Taipalensuu. (2004). Pyrosequencing of TPMT Alleles in a General Swedish Population and in Patients with Inflammatory Bowel Disease. Clinical Chemistry. 50(2). 288–295. 56 indexed citations
16.
Gerhardt, W., Gunnar Nordin, Anders Isaksson, et al.. (2001). More on troponin assays and heparin - Response. Lund University Publications (Lund University). 6 indexed citations
17.
Gerhardt, W., Gunnar Nordin, Anders Isaksson, et al.. (2000). Troponin T and I Assays Show Decreased Concentrations in Heparin Plasma Compared with Serum: Lower Recoveries in Early than in Late Phases of Myocardial Injury. Clinical Chemistry. 46(6). 817–821. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Balsat Breakdown of academic impact, for papers by Hiromichi Take Breakdown of academic impact, for papers by A Lo Breakdown of academic impact, for papers by Susana Sampaio Breakdown of academic impact, for papers by Ana Isabel Piqueras Breakdown of academic impact, for papers by Sonoko Shimoji Breakdown of academic impact, for papers by Francesco Licciardi Breakdown of academic impact, for papers by Florence Aulagnon Breakdown of academic impact, for papers by Christie L. Boils Breakdown of academic impact, for papers by Fatma Tuncay Özgünen
Rankless by CCL
2026